SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO OXIDATION IN FAMILIAL HYPERCHOLESTEROLEMIA

被引:22
作者
RAAL, FJ [1 ]
AREIAS, AJ [1 ]
WAISBERG, R [1 ]
VONARB, M [1 ]
机构
[1] S AFRICAN INST MED RES, JOHANNESBURG 2000, SOUTH AFRICA
基金
英国医学研究理事会;
关键词
FAMILIAL HYPERCHOLESTEROLEMIA; LOW DENSITY LIPOPROTEIN; LIPID OXIDATION; VITAMIN-E;
D O I
10.1016/0021-9150(94)05494-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that oxidative modification of low density lipoprotein (LDL) plays an important role in the pathogenesis of atherosclerosis. Subjects with familial hypercholesterolaemia (FH) have elevated concentrations of LDL and develop premature atherosclerosis. The aim of the study was to determine whether the susceptibility of LDL to in vitro oxidation is increased in FH subjects. LDL was isolated from 15 FH homozygotes (mean age +/- SD, 19 +/- 10 years; mean LDL-cholesterol 16.86 +/- 3.55 mmol/l), 15 FH heterozygotes (38 +/- 13 years; LDL-cholesterol 5.58 +/- 1.78 mmol/l) and 15 normocholesterolaemic subjects (31 +/- 8 years; LDL-cholesterol 3.07 +/- 0.77 mmol/l). Susceptibility of LDL to in vitro copper-mediated oxidation was assessed by measuring conjugated diene production at 234 nm, the lag phase being a measure of the resistance of LDL to oxidation. Unexpectedly, the mean duration of the lag phase was 2.2 fold longer in the FH homozygotes (123.8 +/- 45.0 min) and 1.75-fold longer in the FH heterozygotes(99.9 +/- 40.6 min) than in the controls (57.1 +/- 27.9 min; P < 0.0001). Serum and LDL vitamin E levels were higher in the FH patients, but not when expressed relative to LDL-cholesterol concentration. There was also no correlation between LDL vitamin E concentration and duration of the lag phase. LDL bulk rather than the susceptibility of LDL to oxidation is probably the more important factor for the initiation and progression of atherosclerosis in FH patients.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 32 条
[1]  
AUSTIN M A, 1988, Journal of the American Medical Association, V260, P1917, DOI 10.1001/jama.260.13.1917
[2]  
BJORNSON LK, 1976, J LIPID RES, V17, P343
[3]   SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B [J].
CHAIT, A ;
BRAZG, RL ;
TRIBBLE, DL ;
KRAUSS, RM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :350-356
[4]  
CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
[5]   PREDISPOSITION TO LDL OXIDATION IN PATIENTS WITH AND WITHOUT ANGIOGRAPHICALLY ESTABLISHED CORONARY-ARTERY DISEASE [J].
COMINACINI, L ;
GARBIN, U ;
PASTORINO, AM ;
DAVOLI, A ;
CAMPAGNOLA, M ;
DESANTIS, A ;
PASINI, C ;
FACCINI, GB ;
TREVISAN, MT ;
BERTOZZO, L ;
PASINI, F ;
LOCASCIO, V .
ATHEROSCLEROSIS, 1993, 99 (01) :63-70
[6]  
DEEG R, 1983, CLIN CHEM, V29, P1798
[7]   ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS [J].
DEGRAAF, J ;
HAKLEMMERS, HLM ;
HECTORS, MPC ;
DEMACKER, PNM ;
HENDRIKS, JCM ;
STALENHOEF, AFH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :298-306
[8]  
DIEBERROTHENEDER M, 1991, J LIPID RES, V32, P1325
[9]   EFFECT OF ANTIOXIDANTS ON OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
PUHL, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
RABL, H .
ANNALS OF MEDICINE, 1991, 23 (05) :573-581
[10]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75